News

The collaboration provides GlaxoSmithKline (GSK) access to Mpex’s novel efflux pump inhibitors (EPI) and related proprietary technology for use in combination with a variety of antibiotics. The collaboration

This request is in response to the negative opinion of May 30, 2008, in which the Committee for Medicinal Products for Human Use (CHMP) recommended the refusal of

Humira received approval for manufacturing and distribution in Japan on April 16, 2008, and was listed in the National Health Insurance drug price list on June 13, 2008.

The study was conducted in centres across the US and Europe. The full analysis set includes a total of 557 patients. The study was a randomized, double-blind, placebo-controlled,

The Phase I study showed that TZP-102 has excellent oral bioavailability in man and is safe and well-tolerated at all five doses (10-80 mg) tested. Most importantly, all

The purpose of the trial, named EmbraceAC, is to evaluate whether ATI-5923 is superior to warfarin in its ability to maintain patients within a target therapeutic range of

Most recently, Mr Wulff served as executive vice president and CFO for Artes Medical, a San Diego-based medical technology company. In that position, he assisted the company in

Mr Jacobs has over 30 years of experience in accounting, finance and operations. Since May 2005, he has been CFO and COO of Karat Platinum, which supplies and

In connection with the series A financing, Meritage Pharma announced its founding management team: Cam Garner, chairman; Elaine Phillips, president and CEO; Malcolm Hill, chief scientific officer; and